On 2 October 2026, GAW CAPITAL RE PD OFC filed for a Hong Kong listing with Jefferies as sole sponsor, as the first real estate private debt fund to do so.
On 5 October 2026, TINCI (002709.SZ) passed the Main Board listing hearing of HKEX, with J.P. Morgan, CITIC Securities and GF Securities as joint sponsors.
On 5 October 2026, GAPACK (00468.HK) said the Listing Committee decided to cancel its listing, with delisting due on 20 October 2026 if no review is sought.
On 5 October 2026, WYNN MACAU (01128.HK) announced that it granted awards over a total of 317,938 shares to 315 employees of the Group under its Employee Share Ownership Plan adopted on 25 May 2023, representing approximately 0.01% of its issued share capital as at the date of the announcement, at a nil purchase price.
On 5 October 2026, FW FASHION INT (02528.HK) announced that its existing retail store management agreement arrangement with Pop Mart for operating Pop Mart stores in Macau will terminate with effect from 21 December 2026, with revenue from those stores accounting for approximately 22% of the Group's total revenue for the nine months ended 30 September 2026.
On 5 October 2026, SIHUAN PHARM (00460.HK) announced that five new specifications of the injectable sodium hyaluronate complex solution (product name: Dongyan), developed by its subsidiary Meiyan Space, have been approved for marketing by China's National Medical Products Administration, namely 0.75 mL, 1.25 mL, 1.75 mL, 2.25 mL and 2.75 mL per vial.
Global X Copper Miners ETF (3014.HK) rose 3.16% to HKD 7.665 on Oct 5 as LME copper held above USD 14,300/t and copper miners rallied; premium to NAV is 2.22%.
Xtrackers MSCI Taiwan UCITS ETF (3036.HK) rose 4.12% to HKD 1,314.500 on October 5, up 87.25% in 2026, as China's Taiwan region index and TSMC hit record highs.
On 5 Oct 2026, AGILE GROUP (03383.HK) is close to finalising an RSA for US$5.183bn of offshore debt, with ~64.6% of post-restructuring shares as consideration.
On 4 Oct 2026, BUD APAC (01876.HK) flagged ~US$82m of Q3 charges: ~US$52m reorganisation withholding tax and ~US$30m India receivables provision.
On 4 Oct 2026, LONGSYS (09976.HK) said its IPO stabilisation period ended on 3 Oct; the over-allotment option lapsed, so no more H shares will be issued.
On 2 Oct 2026, PATEO (02889.HK) completed the acquisition of a ~70% stake; the target was valued at RMB2.7bn with consideration capped at RMB1.4bn.
On 2 Oct 2026, WK GROUP (02535.HK) and WellLuck said the mandatory cash offer lapsed as conditions were unmet, with only 30,000 shares (0.0015%) accepted.
On 2 October 2026, GoFintech Quantum Innovation Limited (00290.HK) announced that its Fortune Asset Management Open-ended Fund Company and its two publicly offered sub-funds (the Fortune Asset Technology Select Equity Fund and the Fortune Asset Fixed Income Fund) were approved by the Securities and Futures Commission of Hong Kong on 30 September 2026.
On 2 October 2026, Ascletis Pharma Inc. (01672.HK) announced that key preclinical data for ASC36_35FDC were presented at the 62nd Annual Meeting of the European Association for the Study of Diabete.
As of October 2, 2026, Global X China Semiconductor ETF (03191.HK) fell 5.19% intraday to a latest price of HK$76.320, with a turnover of HK$32.2959 million; the ETF is managed by Mirae Asset Global Investments (Hong Kong) Limited and tracks the FactSet China Semiconductor Index (Net Total Return), with assets under management of HK$2.804 billion and a net asset value per unit of HK$77.99.
